Brevetti EPO No.3321276 2021.07.28
Brevetti EPO
(10) Registration Number and Date
2021000595 2021.12.06
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000595 2012.09.26
(40) Publication Number and Date
SM /T/2021/000595 2021.12.06
(30) Priority Details
US 201161539280 P
2011.09.26
(71/73) Applicant
(72) Inventor
(IT) DANIELS, Douglas S. : Novartis Institutes for BioMedical Research, Inc.100 Technology Square, Cambridge, MA 02139, US
(IT) HAMAMATSU, Norio : Novartis Institutes for BioMedical Research, Inc.100 Technology Square, Cambridge, MA 02139, US
(IT) CAPLAN, Shari L. : Novartis Institutes for BioMedical Research, Inc.100 Technology Square, Cambridge, MA 02139, US
(IT) LICHT, Stuart : Novartis Institutes for BioMedical Research, Inc.100 Technology Square, Cambridge, MA 02139, US
(IT) BOETTCHER, Brian R. : Novartis Institutes for BioMedical Research, Inc.100 Technology Square, Cambridge, MA 02139, US
(IT) WELDON, Stephen Craig : Novartis Institutes for BioMedical Research, Inc.100 Technology Square, Cambridge, MA 02139, US
(74) Representative Name
(IT) SANTI, Filippo : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) PROTEINE DI FUSIONE PER IL TRATTAMENTO DI DISTURBI METABOLICI
(EN) FUSION PROTEINS FOR TREATING METABOLIC DISORDERS
(57) Abstract
(58) Citations